Quick Answer
Q32 Bio Inc. reported Net Income Loss of $29.82 million for the year ending 2025.
- Q32 Bio Inc. showed an increase of +162.5% in Net Income Loss from 2024 to 2025.
- This data is from Q32 Bio Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), Q32 Bio Inc.'s Net Income Loss has grown by 199.4%.
- Historical annual values: Fiscal year 2025: $29.82 million | Fiscal year 2024: -$47.73 million | Fiscal year 2023: -$53.74 million | Fiscal year 2022: -$5.01 million | Fiscal year 2021: -$95.76 million | Fiscal year 2020: -$128.69 million | Fiscal year 2019: -$103.92 million | Fiscal year 2018: -$55.58 million | Fiscal year 2017: -$29.99 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: